Approval · Notice of Compliance 5401 · 1994
ORAMORPH SR: Notice of Compliance 5401
Issued April 27, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5401
- Date
- April 27, 1994
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in final dosage form and formulation
- Therapeutic class
- Narcotic analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORAMORPH SR | Not yet assigned | — |
Medicinal ingredients
- MORPHINE SULFATE 30 MG per TAB